NASDAQ:TRVN

Trevena Stock Insider Trading

Healthcare > Biotechnology

Buy TRVN

*Your capital is at risk

$0.0010

+0 (+0%)

At Close: Jun 03, 2026

Trevena Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 91.24. In total, the insiders bought 2.43M and sold 86.14K TRVN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	91.24
● Buy	2.43M shares
● Sell	86.14K shares
36% Buy Activity Negligible or No Correlation
Buy Signal Medium Confidence Jun 01, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 91.24. Confidence increased due to high data reliability score of 80.

Historical Insider Trades

Date	Type	Person	Role	Amount
Dec 14, 2023 Buy	Common Stock A-Award	Drake Patricia M. SVP, Chief Commercial Officer	Officer	25 000 Value: $15.3K
Dec 14, 2023 Sell	Common Stock F-InKind	Drake Patricia M. SVP, Chief Commercial Officer	Officer	1 835 Value: $1K
Dec 14, 2023 Buy	Common Stock A-Award	Drake Patricia M. SVP, Chief Commercial Officer	Officer	50 000 Value: $30.5K
Dec 14, 2023 Buy	Common Stock A-Award	Bourdow Carrie L. President & CEO	CEO / President	100 000 Value: $61.0K
Dec 14, 2023 Sell	Common Stock F-InKind	Bourdow Carrie L. President & CEO	CEO / President	7 123 Value: $4K
Dec 14, 2023 Buy	Common Stock A-Award	Bourdow Carrie L. President & CEO	CEO / President	370 000 Value: $225.7K
Dec 14, 2023 Buy	Common Stock A-Award	Shin Barry SVP, CFO	C-Suite Officer	50 000 Value: $30.5K
Dec 14, 2023 Sell	Common Stock F-InKind	Shin Barry SVP, CFO	C-Suite Officer	3 616 Value: $2K
Dec 14, 2023 Buy	Common Stock A-Award	Shin Barry SVP, CFO	C-Suite Officer	185 000 Value: $112.9K
Dec 14, 2023 Buy	Common Stock A-Award	Demitrack Mark SVP, Chief Medical Officer	Officer	50 000 Value: $30.5K
Dec 14, 2023 Sell	Common Stock F-InKind	Demitrack Mark SVP, Chief Medical Officer	Officer	3 593 Value: $2K
Dec 14, 2023 Buy	Common Stock A-Award	Demitrack Mark SVP, Chief Medical Officer	Officer	185 000 Value: $112.9K
Dec 14, 2023 Buy	Common Stock A-Award	Yoder Robert T SVP, Chief Business Officer	Officer	25 000 Value: $15.3K
Dec 14, 2023 Sell	Common Stock F-InKind	Yoder Robert T SVP, Chief Business Officer	Officer	1 929 Value: $1K
Dec 14, 2023 Buy	Common Stock A-Award	Yoder Robert T SVP, Chief Business Officer	Officer	92 500 Value: $56.4K
Dec 14, 2023 Buy	Common Stock A-Award	Demitrack Mark SVP, Chief Medical Officer	Officer	185 000 Value: $112.9K
Dec 14, 2023 Buy	Common Stock A-Award	Yoder Robert T SVP, Chief Business Officer	Officer	92 500 Value: $56.4K
Dec 14, 2023 Sell	Common Stock F-InKind	Yoder Robert T SVP, Chief Business Officer	Officer	1 929 Value: $1K
Dec 14, 2023 Buy	Common Stock A-Award	Yoder Robert T SVP, Chief Business Officer	Officer	25 000 Value: $15.3K
Dec 14, 2023 Sell	Common Stock F-InKind	Demitrack Mark SVP, Chief Medical Officer	Officer	3 593 Value: $2K
Dec 14, 2023 Buy	Common Stock A-Award	Demitrack Mark SVP, Chief Medical Officer	Officer	50 000 Value: $30.5K
Dec 14, 2023 Buy	Common Stock A-Award	Shin Barry SVP, CFO	C-Suite Officer	185 000 Value: $112.9K
Dec 14, 2023 Sell	Common Stock F-InKind	Shin Barry SVP, CFO	C-Suite Officer	3 616 Value: $2K
Dec 14, 2023 Buy	Common Stock A-Award	Shin Barry SVP, CFO	C-Suite Officer	50 000 Value: $30.5K
Dec 14, 2023 Buy	Common Stock A-Award	Bourdow Carrie L. President & CEO	CEO / President	370 000 Value: $225.7K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT TREVENA

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV027 for the treatment of acute lung injury contributing to acute respiratory distress syndrome and abno...

Read Full Profile Here